Terms: = Bone cancer AND CTLA4, ALPS5, CD, CD152, CELIAC3, CTLA-4, GRD4, GSE, IDDM12 AND Treatment
227 results:
1. Severe autoimmune hemolytic anemia following immunotherapy with checkpoint inhibitors in two patients with metastatic melanoma: a case report.
Fetter T; Fietz S; Bertlich M; Braegelmann C; de Vos-Hillebrand L; Wenzel J; Heine A; Landsberg J; Jansen P
Front Immunol; 2024; 15():1342845. PubMed ID: 38571955
[TBL] [Abstract] [Full Text] [Related]
2. Charting a path forward: Promising outcomes of convalescent plasma therapy in the care of severely B-cell depleted patients with persistent COVID-19.
Inbar T; Dann EJ; Kerner O; Stern A
Transfusion; 2024 Mar; 64(3):443-448. PubMed ID: 38327238
[TBL] [Abstract] [Full Text] [Related]
3. Unraveling T cell exhaustion in the immune microenvironment of osteosarcoma via single-cell RNA transcriptome.
Cheng D; Zhang Z; Liu D; Mi Z; Tao W; Fu J; Fan H
Cancer Immunol Immunother; 2024 Jan; 73(2):35. PubMed ID: 38280005
[TBL] [Abstract] [Full Text] [Related]
4. Immune Modulation with RANKL Blockade through Denosumab treatment in Patients with cancer.
Chang H; Marquez J; Chen BK; Kim DM; Cheng ML; Liu EV; Yang H; Zhang L; Sinha M; Cheung A; Kwek SS; Chow ED; Bridge M; Aggarwal RR; Friedlander TW; Small EJ; Anderson M; Fong L
Cancer Immunol Res; 2024 Apr; 12(4):453-461. PubMed ID: 38276989
[TBL] [Abstract] [Full Text] [Related]
5. Evaluating the efficacy of combination and single-agent immunotherapies in real-world patterns of disease progression and survival of metastatic melanoma patients.
Ko B; Tao K; Brennan L; Rakhade S; Chan CX; Moone JY; Zhu R; Sher A; Wang S; Bracero Y; Fullerton B; McLellan B; Geskin LJ; Saenger YM
Melanoma Res; 2024 Apr; 34(2):134-141. PubMed ID: 38181115
[TBL] [Abstract] [Full Text] [Related]
6. Clinical and therapeutical significances of the cluster and signature based on oxidative stress for osteosarcoma.
Ding M; Ran X; Qian S; Zhang Y; Wang Z; Dong M; Yang Z; Wu S; Feng X; Zhang J; Zhu L; Niu S; Zhang X
Aging (Albany NY); 2023 Dec; 15(24):15360-15381. PubMed ID: 38180104
[TBL] [Abstract] [Full Text] [Related]
7. Sequential immunotherapy and targeted therapy for metastatic BRAF V600 mutated melanoma: 4-year survival and biomarkers evaluation from the phase II SECOMBIT trial.
Ascierto PA; Casula M; Bulgarelli J; Pisano M; Piccinini C; Piccin L; Cossu A; Mandalà M; Ferrucci PF; Guidoboni M; Rutkowski P; Ferraresi V; Arance A; Guida M; Maiello E; Gogas H; Richtig E; Fierro MT; Lebbe C; Helgadottir H; Queirolo P; Spagnolo F; Tucci M; Del Vecchio M; Cao MG; Minisini AM; De Placido S; Sanmamed MF; Mallardo D; Paone M; Vitale MG; Melero I; Grimaldi AM; Giannarelli D; Dummer R; Sileni VC; Palmieri G
Nat Commun; 2024 Jan; 15(1):146. PubMed ID: 38167503
[TBL] [Abstract] [Full Text] [Related]
8. Features of the TCR repertoire associate with patients' clinical and molecular characteristics in acute myeloid leukemia.
Pospiech M; Tamizharasan M; Wei YC; Kumar AMS; Lou M; Milstein J; Alachkar H
Front Immunol; 2023; 14():1236514. PubMed ID: 37928542
[TBL] [Abstract] [Full Text] [Related]
9. Case Report: Durable complete response of metastatic hepatocellular carcinoma with asymptomatic hyperamylasemia to combined immunotherapy of anti-cytotoxic T lymphocyte-associated antigen 4 plus anti-programmed cell death-1 antibodies.
Gao H; Chang RZ; Chen XP; Zhang WG; Zhang B; Luo X; Ding ZY
Front Immunol; 2023; 14():1274449. PubMed ID: 37869012
[TBL] [Abstract] [Full Text] [Related]
10. Effect of transplanted cells with CD184 and CD26 expressions and reconstitution of CD3+ lymphocyte population on long-term survival after autologous hematopoietic stem cell transplantation for multiple myeloma.
Kopinska A; Krawczyk-Kulis M; Wieczorkiewicz-Kabut A; Koclega A; Jagoda K; Dziaczkowska-Suszek J; Helbig G
Exp Hematol; 2023 Nov; 127():52-58.e1. PubMed ID: 37666354
[TBL] [Abstract] [Full Text] [Related]
11. [Discovery of RANKL and the current and future impact of its research].
Yasuda H
Nihon Yakurigaku Zasshi; 2023; 158(3):247-252. PubMed ID: 37121707
[TBL] [Abstract] [Full Text] [Related]
12. Hemophagocytic lymphohistiocytosis in inflammatory bowel disease: a nationwide analysis.
Mahmoud AA; Abdelhay A; Khamis A; Mostafa M; Shehadah A; Mohamed MS; Eltaher B; Malik T
Ann Hematol; 2023 Jul; 102(7):1705-1711. PubMed ID: 37093242
[TBL] [Abstract] [Full Text] [Related]
13. Inappropriate Expression of PD-1 and ctla-4 Checkpoints in Myeloma Patients Is More Pronounced at Diagnosis: Implications for Time to Progression and Response to Therapeutic Checkpoint Inhibitors.
Kulikowska de Nałęcz A; Ciszak L; Usnarska-Zubkiewicz L; Pawlak E; Frydecka I; Szmyrka M; Kosmaczewska A
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982802
[TBL] [Abstract] [Full Text] [Related]
14. Nitazoxanide inhibits acetylated KLF5-induced bone metastasis by modulating KLF5 function in prostate cancer.
Huang Q; Liu M; Zhang D; Lin BB; Fu X; Zhang Z; Zhang B; Dong JT
BMC Med; 2023 Feb; 21(1):68. PubMed ID: 36810084
[TBL] [Abstract] [Full Text] [Related]
15. Dysfunctions of innate and adaptive immune tumor microenvironment in Waldenström macroglobulinemia.
Cholujova D; Beke G; Hunter ZR; Hideshima T; Flores L; Zeleznikova T; Harrachova D; Klucar L; Leiba M; Drgona L; Treon SP; Kastritis E; Dorfman DM; Anderson KC; Jakubikova J
Int J Cancer; 2023 May; 152(9):1947-1963. PubMed ID: 36533670
[TBL] [Abstract] [Full Text] [Related]
16. Anti-Thymocyte Globulin (ATG)-Free Nonmyeloablative Haploidentical PBSCT Plus Post-Transplantation Cyclophosphamide Is a Safe and Efficient treatment Approach for Pediatric Acquired Aplastic Anemia.
Chen RL; Ip PP; Shaw JJ; Wang YH; Fan LH; Shen YL; Joseph NA; Chen TE; Chen LY
Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499545
[TBL] [Abstract] [Full Text] [Related]
17. Therapeutic targets and biomarkers of tumor immunotherapy: response versus non-response.
Wang DR; Wu XL; Sun YL
Signal Transduct Target Ther; 2022 Sep; 7(1):331. PubMed ID: 36123348
[TBL] [Abstract] [Full Text] [Related]
18. Immune Phenotypes and Target Antigens of Clonally Expanded bone Marrow T Cells in treatment-Naïve Multiple Myeloma.
Welters C; Lammoglia Cobo MF; Stein CA; Hsu MT; Ben Hamza A; Penter L; Chen X; Buccitelli C; Popp O; Mertins P; Dietze K; Bullinger L; Moosmann A; Blanc E; Beule D; Gerbitz A; Strobel J; Hackstein H; Rahn HP; Dornmair K; Blankenstein T; Hansmann L
Cancer Immunol Res; 2022 Nov; 10(11):1407-1419. PubMed ID: 36122410
[TBL] [Abstract] [Full Text] [Related]
19. Single-intraosseous simvastatin injection suppresses cancers via activating CD8
Yuan W; Ren X; Zhu J; Huang J; Zhang W; Zhang C; Guan Z; Wang H; Leng H; Song C
Biomed Pharmacother; 2022 Nov; 155():113665. PubMed ID: 36095962
[TBL] [Abstract] [Full Text] [Related]
20. Using the canine microbiome to bridge translation of cancer immunotherapy from pre-clinical murine models to human clinical trials.
Kleber KT; Iranpur KR; Perry LM; Cruz SM; Razmara AM; Culp WTN; Kent MS; Eisen JA; Rebhun RB; Canter RJ
Front Immunol; 2022; 13():983344. PubMed ID: 36032113
[TBL] [Abstract] [Full Text] [Related]
[Next]
